Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 309-203-1 | CAS number: 100085-61-8 Substance obtained by acidic, alkaline, or enzymatic hydrolysis of mixed animals composed primarily of amino acids, peptides, and proteins. It may contain impurities consisting chiefly of carbohydrates and lipids along with smaller quantities of miscellaneous organic substances of biological origin.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Short-term toxicity to fish
Administrative data
- Endpoint:
- short-term toxicity to fish
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: scientifically accepted study
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of different dietary levels of fish protein hydrolysates on growth, digestive enzymes, gut microbiota, and resistance to Vibrio anguillarum in European sea bass (Dicentrarchus labrax) larvae
- Author:
- Y.P. Kotzamanis, E. Gisbert, F.J. Gatesoupe, J. Zambonino Infante, C. Cahu
- Year:
- 2 007
- Bibliographic source:
- Comparative Biochemistry and Physiology, Part A 147 (2007) 205–214
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Four compound diets were formulated (Table 1). In diets S19 and C19, the protein hydrolysate – consisting of sardine silage (SH, 42% crude protein) and a commercial enzymatic FPH (CPSP, Concentré Protéique soluble de Poisson, Sopropêche,
Boulogne-sur-Mer, France, 82% crude protein), respectively – was incorporated at a level of 19%. The remaining of the dietary protein fraction was supplied by fishmeal (Norse LT 94). The diet with 19% CPSP (C19) corresponded to the one that gave the best results when tested by Cahu et al. (1999), and was used as a control. In diets S10 and C10, replacement of fishmeal with sardine silage or CPSP was limited to 10%. The ingredients were mixed with water, pelletized and dried at 60 °C for 25 min. The pellets were then sieved to obtain a particle size of 200–400 μm.
At 17 and 26 dph, 20 larvae from each rearing tank were sampled before the daily food distribution to count bacteria, according to the methods previously described (Gatesoupe, 1995). - GLP compliance:
- not specified
Test material
- Reference substance name:
- fish protein hydrolysates
- IUPAC Name:
- fish protein hydrolysates
- Details on test material:
- Two fish protein hydrolysates (FPH) were incorporated into four diets prepared for start-feeding sea bass larvae, at two different levels (10%
and 19% of total ingredients): a commercial FPH, CPSP, in which the molecular mass of the main fraction of soluble peptides (51%) was between
500–2500 Da, and an experimental FPH obtained by acidic silage of sardine offal, SH, with a main portion of soluble peptides (54%) ranging
from 200 to 500 Da.
Constituent 1
Sampling and analysis
- Analytical monitoring:
- yes
Test solutions
- Vehicle:
- no
Test organisms
- Test organisms (species):
- other: European sea bass (Dicentrarchus labrax) larvae
Study design
- Test type:
- flow-through
- Water media type:
- freshwater
- Limit test:
- no
- Total exposure duration:
- 33 d
Results and discussion
Effect concentrations
- Duration:
- 33 d
- Dose descriptor:
- LOEC
- Effect conc.:
- 19 other: %
- Nominal / measured:
- nominal
- Conc. based on:
- act. ingr.
Any other information on results incl. tables
- Sublethal observations / clinical signs:
After 3 days of challenging with V. anguillarum, the larvae fed on diet S19 until 16 dph presented a significantly lower
mortality rate than those of groups C10 and C19 in one-way analysis (9 vs. 19–23%, Table 6). Meanwhile, mortality was
between 0% and 2% in control bottles without infection, except in one corresponding to diet S10 (5%). Two-way analysis of
variance indicated that the dose of FPH had no effect on mortality after infection, and that interaction was not significant,
whereas the difference due to the type of hydrolysate was highly significant.
Applicant's summary and conclusion
- Validity criteria fulfilled:
- not applicable
- Conclusions:
- In the present study, two types of fish protein hydrolysates and two dietary inclusion levels were tested in the diets of sea bass larvae from mouth opening until day 33. The main differences between the hydrolysates related to the molecular weight distribution of their peptides and their degree of solubility, both of which originated from the different hydrolysis procedures applied. The results indicated that SH hydrolysates were less soluble and contained a larger proportion of short peptides, namely di-/tripeptides, than CPSP hydrolysate. Amino acid analysis was not performed, since little
variation was observed in the amino acid composition of either FPH or fishmeal produced from different fish species (Hertrampf and Piedad-Pascual, 2000).
The incorporation of CPSP hydrolysates (treatment C10) in the diet at a concentration of 10% effectively improved growth, survival and the intestinal development of sea bass larvae. At 15 dph, the diets with low replacement rates for fishmeal by FPH (10% of total ingredients) produced improved growth of sea bass larvae with respect to diets with higher replacement rates of 19%, such as those already tested by Cahu et al. (1999).
After that day and until the end of the trial (day 33), the best growth and survival rates were obtained with the low dose of CPSP, whereas the worst was observed with the low dose of the experimental sardine hydrolysate
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.